A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

NCT06203002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

496

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG: Placebo (blinded)
DRUG: LX9211 (blinded)

Sponsor

Lexicon Pharmaceuticals